Research from Doulatov Lab in the Journal Blood Offers Stem Cell-Aided Insights on MDS Onset
June 13, 2019 | Categories: Research |Myelodysplastic syndromes (MDS) are heterogenous blood disorders that affect up to 170,000 people in the United States, primarily over the age of 60. While early symptoms, including anemia (characterized by fatigue), are not serious, MDS is a high-risk factor for leukemia. Currently there are few treatment for MDS and the causes remain poorly understood. Read More
Studying Cell Signaling in the Prostate
April 15, 2019 | Categories: Core Faculty, Research |While prostate cancer may not be as deadly as other cancers – five-year survival rates can exceed 90%, especially if the disease is localized – incidence rates overall are increasing. For 2019 alone, The American Cancer Society predicts the United States will see roughly 175,000 new cases and 32,000 deaths associated with prostate cancer. Read More
Study tells of cancer patient’s unprecedented level of care
January 25, 2016 | Categories: Research |32 researchers at 14 institutions joined to identify personalized treatment options for woman with metastatic triple-negative breast cancer A new report documents one cancer patient’s experience with an unprecedented level of individualized care, provided through the University of Washington Center for Cancer Innovation. In the study, 32 experts from 14 institutions teamed to identify potential interventions for a patient […] Read More